in this issue
Markets :: Alternative Fuels :: Biorefineries
French biotech firm in talks for biobased isobutene contract
2:09 PM MDT | October 28, 2013 | Rebecca Coons
Biochemical company Global Bioenergies (Evry, France) announced today that it has reached the main milestone in a 2010 license option agreement with an unnamed Fortune 500 industrialist based in the United States, triggering an exclusive negotiation period for a follow-on contract for Global Bioenergies' biobased isobutene. According to the terms of the 2010 agreement, a license option was granted to the industrialist for a maximum of three years. If, during these three years, a specific technical milestone in the development of the isobutene program was hit by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee